Given the strong link between CSF MERTK and symptomatic GRN-FTD, we next asked whether CSF MERTK exhibited a similar pattern at the symptomatic stage of other genetic FTDs, specifically C9orf72 and MAPT mutation carriers. The gene discussed is CSF2; the disease is frontotemporal dementia.